{
    "Trade/Device Name(s)": [
        "TAP Blood Collection\u00ae Device"
    ],
    "Submitter Information": "Seventh Sense Biosystems, Inc.",
    "510(k) Number": "K161521",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022130"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PRJ"
    ],
    "Summary Letter Date": "January 10, 2017",
    "Summary Letter Received Date": "January 17, 2017",
    "Submission Date": "February 14, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood specimen collection device"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        "TAP Blood Collection\u00ae Device (lithium heparin coated, integrated reservoir)"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Capillary action",
        "Vacuum extraction",
        "Microneedles"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for TAP Blood Collection\u00ae Device, a single-use, lithium heparin-coated capillary blood collection system for HbA1c analysis.",
    "Indications for Use Summary": "For healthcare worker use to collect capillary blood from the upper arm of adults (21+ years) for laboratory analysis of HbA1c to monitor glycemic control.",
    "fda_folder": "Clinical Chemistry"
}